Top Financing News - August 12th

The Recap

The best information on capital raises and financing activity in under 5 minutes:

• Lucid Group, Inc. (NASDAQ: LCID) Announces $750 Million Convertible Preferred Investment and $750 Million Delayed Draw Term Loan

• Filo Corp. (TSX:FIL) Announces Closing of $83 Million Private Placement

• Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Announces Pricing of Public Offering for $75 Million

Lucid Group, Inc. announced that it has entered into agreements with its majority stockholder, Ayar Third Investment Company (an affiliate of the Public Investment Fund), to secure $750,000,000 through the sale of convertible preferred stock via private placement. Additionally, Ayar will provide a $750,000,000 unsecured delayed draw term loan facility, subject to certain terms and conditions. Lucid is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. The flagship vehicle, Lucid Air, delivers best-in-class performance and efficiency. Lucid is currently preparing its state-of-the-art, vertically integrated factory in Arizona to begin production of the Lucid Gravity SUV. The company's goal is to accelerate humanity's transition to sustainable transportation and energy through the creation of the most advanced EVs.

Filo Corp. has successfully completed its private placement, issuing 3,484,848 common shares at C$33.00 per share, raising a total of $83,675,128. The shares were purchased by BHP and Lundin Mining Corporation through subscription agreements. Filo is a Canadian exploration and development company focused on advancing its 100% owned Filo del Sol copper-gold-silver deposit located in San Juan Province, Argentina and adjacent Region III, Chile. Filo is a member of the Lundin Group of Companies.

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. The Company’s mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. MindMed is developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. The Company announced the pricing of a public offering, selling 9.3 million common shares at $7.00 each and issuing pre-funded warrants for 1.4 million more at $6.999 each. The total expected proceeds are about $75,000,000, before expenses. The funds will be used for research, development, and general corporate purposes.

Weekly Money Moves

Lead Investors

• Lucid Motors: $750,000,000 | Automotive | Lead Investor: Ayar Third

  Investment Company

• Tenax Therapeutics: $100,000,000 | Biotechnology | Lead Investor: BVF Partners

• LanzaTech: $40,000,000 | Energy | Lead Investor: Carbon Direct Capital

• Orezone Resources: $47,285,724 | Mining | Lead Investor: Nioko Resources

Do you know of any other lead investors who put capital into the markets this week? We would be happy to feature the transactions, send us an email at [email protected]